1
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Unknown status
Pegylated Liposomal Doxorubicin: 2470 Clinical Trials, Page 1 of 247
Hide Studies Not Open or Pending
2
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Condition(s):Stage III Adult Soft Tissue SarcomaLast Updated:February 21, 2021Unknown status
3
Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Condition(s):Breast CancerLast Updated:July 19, 2017Completed
4
Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients
Condition(s):Ovarian Neoplasm Epithelial; High Grade Serous CarcinomaLast Updated:January 14, 2020Unknown status
5
MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)
Condition(s):Ovarian CancerLast Updated:October 19, 2016Terminated
6
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Condition(s):Kaposi Sarcoma; HIV-1-infectionLast Updated:January 25, 2023Not yet recruiting
7
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
Condition(s):Neoplasms, OvarianLast Updated:July 21, 2017Completed
8
Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer
Condition(s):Ovarian CancerLast Updated:November 13, 2017Unknown status
9
Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition(s):Liver NeoplasmsLast Updated:July 4, 2013Withdrawn
10
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Condition(s):HER-2 Positive Breast Cancer; Malignant Neoplasm of BreastLast Updated:February 2, 2016Terminated